Condition: Neovascular Age-related Macular Degeneration · nAMD · Sponsor: Amgen
The aim of this trial is to demonstrate similarity in efficacy between ABP 938 8 mg and aflibercept (US) 8 mg by evaluating the change in best corrected visual acuity (BCVA) in participants with neovascular age-related macular degeneration (nAMD)
This description comes directly from the study's public registry record.
Amgen Call Center · 866-572-6436 · medinfo@amgen.com
Always discuss trial participation with your own doctor first.
| Retina Consultants of Orange County | Fullerton, California, United States | Recruiting |
| South Coast Retina Center - RCA | Long Beach, California, United States | Recruiting |
| Retinal Consultants Medical Group, Inc.-Sacramento, Greenback Lane, (RCA) | Modesto, California, United States | Recruiting |
| California Eye Specialists Medical Group, Inc | Pasadena, California, United States | Recruiting |
| Retinal Consultants Medical Group, Inc - Sacramento - Parkcenter Drive (RCA) | Sacramento, California, United States | Recruiting |
| California Retina Consultants | Santa Barbara, California, United States | Recruiting |
| Retina Consultants of Southern Colorado (Colorado Springs)- RCA | Colorado Springs, Colorado, United States | Recruiting |
| Retina Group of New England | Waterford, Connecticut, United States | Recruiting |
| Medeye Associates - Research | Miami, Florida, United States | Recruiting |
| Retina Consultants of Southwest Florida - Naples | Naples, Florida, United States | Recruiting |
| Advanced Research, LLC | Pensacola, Florida, United States | Recruiting |
| Retina Associates | Elmhurst, Illinois, United States | Recruiting |
+ 24 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07614776